Is INH compatible with G6PD patients?

Isoniazid (INH) is generally considered safe for patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, but caution is advised. While INH is not a known hemolytic agent, individual responses can vary. It's important for G6PD-deficient patients to be monitored for any adverse reactions when taking any new medication, including INH, and to consult with their healthcare provider before starting treatment.